What should personalized, precision treatment of cancer look like in the future?
We know that people are different, their tumors are different, and they respond differently to different therapies. Medical teams of the future might be able to create a ?“virtual twin” of a person and their tumor. Then, by tapping supercomputers, physician-led teams could simulate how tumor cells behave to test millions (or billions) of possible treatment combinations. Ultimately, the best combinations might offer clues towards a personalized, effective treatment plan.
Sound like wishful thinking? The first steps towards this vision have been undertaken by a multi-institution research collaboration that includes Jonathan Ozik and Nicholson Collier, computational scientists at the U.S. Department of Energy’s Argonne National Laboratory.
The research team, which includes collaborators at Indiana University and the University of Vermont Medical Center, brought the power of high-performance computing to the thorny challenge of improving cancer immunotherapy. The team tapped twin supercomputers at Argonne and the University of Chicago, finding that high-performance computing can yield clues in fighting cancer, as discussed in a June 7 article published in Molecular Systems Design and Engineering.
“With this new approach, researchers can use agent-based modeling in more scientifically robust ways.” — Nicholson Collier, computational scientist at Argonne and the University of Chicago
Standing up to cancer
Cancer immunotherapy is a promising treatment that realigns your immune system to reduce or eliminate cancer cells. The therapy, however, helps only 10 to 20 percent of patients — partly because the way in which cancer cells and immune cells mingle is complex and poorly understood. Proven rules are scarce.
To begin uncovering the rules of immunotherapy, the team turned to a set of three tools:
- Agent-based modeling, which predicted the behavior of individual ?“agents” – cancer and immune cells, in this case
- Argonne’s award-winning workflow technology to take full advantage of the supercomputers
- A guiding framework to explore models and dynamically direct and track results
The trio operate in a hierarchy. The framework, developed by Ozik, Collier, Argonne colleagues, and Gary An, a surgeon and professor at the University of Vermont Medical Center, is called Extreme-scale Model Exploration with Swift (EMEWS). It oversees the agent-based model and the workflow system, the Swift/T parallel scripting language, developed at Argonne and the University of Chicago.
What is unique about this combination of tools? ?“We are helping more people in a variety of computational science fields to do large-scale experimentation with their models,” said Ozik, who — like Collier — holds a joint appointment at the University of Chicago. ?“Building a model is fun. But without supercomputers, it is difficult to really understand the full potential of how models can behave.”
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- Digital twins for personalized medicine - a critical assessmenton January 22, 2020 at 3:11 pm
The aim of Digital Twins is to realize Personalized Medicine by identifying deviations from normal. It is questionable how feasible this is at our current level of knowledge. However, there are ...
- Keeping Up with Personalized Medicine: Adapting to Meet Patients’ Needson January 22, 2020 at 10:02 am
Personalized treatments target individual patient needs, so collecting clinical data on large patient populations may not be feasible. Could real-world data collection provide the needed evidence?
- Personalized Medicine Market Size Poised to Touch US$1.7 Trillion up to 2026on January 19, 2020 at 9:33 pm
Introduction According to Acumen Research, the global Personalized Medicine Market is expected to surpass ...
- Laura van 't Veer, PhD, Co-Inventor of MammaPrint, Honored with the PMWC Luminary Award at Precision Medicine World Conference 2020on January 17, 2020 at 5:00 am
This award recognizes those individuals who have made significant contributions to accelerate personalized medicine within the clinical setting. As a Professor of Laboratory Medicine and Director of ...
- Personalized Medicine Market 2019 Global Industry Size, Share, Growth, Segments, Revenue, Key Players and Forecast to 2026on January 16, 2020 at 3:24 am
Introduction The worldwide Personalized Medicine Market will increase by a CAGR of approximately 9.1% ...
- Personalized Medicine Market 2026 – Global Size, Key Companies, Trends, Future Growth Analysis and Regional Forecasts Researchon January 16, 2020 at 1:08 am
The rising number of clinical trials on neurology and other disciplines of healthcare is propelling the growth of the personalized medicine market, says Fortune Business insights in a report, titled ...
- Radiomics for personalised medicine: the long road aheadon January 14, 2020 at 3:22 pm
Leijenaar, R. T., Deist, T. M., Peerlings, J., De Jong, E. E., Van Timmeren, J. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749 (2017).
- The big opportunity in AI, genomics & precision medicine: UPMC clinical analytics chief Dr. Oscar Marroquinon January 14, 2020 at 9:55 am
It also has an Institute for Precision Medicine dedicated to biomedical research and personalized care. Here, Dr. Marroquin discusses how data is revolutionizing clinical care and the most exciting ...
- Antibody technologies take a step closer to precision medicineon January 14, 2020 at 6:46 am
It aims to make the treatment of cancer smarter by customizing the drugs for the specific patient. This is also known as personalized medicine. The concept of precision medicine is not new. In 2015, ...
- Our body systems age at different rates, study finds, pointing to personalized care to extend healthy lifeon January 14, 2020 at 6:11 am
“It’s an important first step toward showing how different parts of a body in different people can age at different rates.” Call it personalized medicine for aging. “Individuals are aging at different ...
via Bing News